HROW stock forecast
Our latest prediction for Harrow Health, Inc.'s stock price was made on the July 9, 2020 when the stock price was at 4.71$.
In the short term (2weeks), HROW's stock price should underperform the market by -0.98%. During that period the price should oscillate between -7.99% and +11.07%.
In the medium term (3months), HROW's stock price should underperform the market by -7.18%. During that period the price should oscillate between -28.40% and +24.40%.Get email alerts
Create a solid portfolio with HROW
About Harrow Health, Inc.
Harrow Health, Inc. engages in the development, production, and sale of innovative medications. It operates through the Pharmaceutical Compounding and Pharmaceutical Drug Development segments. The Pharmaceutical Compounding segment focuses on the operations of ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
At the moment the company generates 51M USD in revenues.
On its last earning announcement, the company reported a loss of -0.95$ per share.
The book value per share is 0.60$
Three months stock forecastJuly 9, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|